Skip to content

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04416061
Acronym
COVID-19
Enrollment
2510
Registered
2020-06-04
Start date
2020-05-11
Completion date
2020-07-31
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID

Brief summary

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium & Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff. Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Interventions

DIAGNOSTIC_TESTCOVID 19 Diagnostic Test

COVID 19 Diagnostic Test

Sponsors

Hong Kong Sanatorium & Hospital
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects who underwent COVID-19 test in HKSH during the study period

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Proportion of asymptomatic subjects1 Feb 2020 until the 14th consecutive day without any local infection in Hong KongProportion of asymptomatic subjects (%) who underwent COVID 19 test

Secondary

MeasureTime frameDescription
Proportion of subjects with recent contact history1 Feb 2020 until the 14th consecutive day without any local infection in Hong KongProportion of subjects (%) with recent contact history
Proportion of subjects with recent travel history1 Feb 2020 until the 14th consecutive day without any local infection in Hong KongProportion of subjects (%) with recent travel history

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026